Agios Pharmaceuticals, Inc. (0HB0.L) LSE

28.75

+4.1557(+16.90%)

Updated at December 24 06:33PM

Currency In USD

Agios Pharmaceuticals, Inc.

Address

88 Sidney Street

Cambridge, MA 02139-4169

United States of America

Phone

617 649 8600

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Employees

486

First IPO Date

January 29, 2018

Key Executives

NameTitlePayYear Born
Brian GoffChief Executive Officer & Director1.55M1969
Craig ThompsonCo-Founder50,0001953
Lewis Clayton CantleyCo-Founder50,0001949
Shin-San SuCo-Founder50,0001956
Tak Wah MakCo-Founder50,0001946
Cecilia JonesChief Financial Officer802,5741975
James William BurnsCorporate Secretary & Chief Legal Officer815,7321978
Tsveta MilanovaChief Commercial Officer836,6431977
Sarah GheuensChief Medical Officer and Head of Research & Development927,5721980
T. J. WashburnVP, Controller & Principal Accounting Officer01982

Description

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.